Podiatrists in Emporia, VA Accepting Medicare

4 Podiatrists found. Showing 1 - 4

Goode 2 Feet Podiatrist Medicare: Medicare Enrolled Practice Location: 425 S Main St Ste F, Emporia, VA 23847 Phone: 434-348-3130    Fax: 804-745-3468

Optimum Foot Care, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1175 Chapmans Ford Rd, Emporia, VA 23847 Phone: 757-537-8680

Antoinette D Adams, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 137 Baker St, Emporia, VA 23847 Phone: 434-336-9001    Fax: 434-336-9229

Adams Comprehensive Foot Care Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 137 Baker St, Emporia, VA 23847 Phone: 434-336-9001    Fax: 434-336-9229

News Archive

Ascendis Pharma's total revenue decreases 50% to €1.9 million in second quarter 2015

Ascendis Pharma A/S, a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced financial results for the three and six months ended June 30, 2015.

Lerner Medical Devices' Levia receives FDA clearance

Lerner Medical Devices, Inc. announced today that Levia®, a novel, in-home, ultraviolet B (UVB) phototherapy device, has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for treatment of psoriasis and certain other skin conditions such as vitiligo.

Alexza completes FDA review for AZ-004 NDA

Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.

Couples with infertility and miscarriages offered detailed embryo screening with 99% accuracy

Termed "preimplantation genetic screening (PGS)" the process involves a full chromosome count of embryos to ensure only the healthiest are implanted. It has a 99 per cent accuracy rate, giving hopeful parents the best chance to conceive and carry a healthy baby to term.

Small Phase I trial shows HIV vaccine candidate is most powerful to date

Researchers at the Spanish Superior Scientific Research Council (CSIC) have successfully completed a small Phase I human clinical trial of an HIV vaccine candidate that granted 90 percent of 30 study participants an immunological response against the virus, Gizmag reports.

Read more Medical News

› Verified 4 days ago